Share chart Suven Pharmaceuticals Limited
About Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited работает как биофармацевтическая компания в Индии, США, Европе и за рубежом. Она разрабатывает, производит и продает новые промежуточные химические соединения, активные фармацевтические ингредиенты, специальные химикаты и лекарственные препараты в рамках контрактных исследований и производственных услуг для фармацевтических, биотехнологических и химических компаний. Компания была зарегистрирована в 2018 году, ее штаб-квартира находится в Хайдарабаде, Индия. more detailsISIN | INE03QK01018 |
---|---|
Industry | Pharmaceuticals |
Sector | Health Care |
Валюта | inr |
Валюта отчета | inr |
Див.доход ао | 1.74 |
Дивиденд ао | 6 |
Сайт | https://suvenpharm.com |
Цена ао | 1148.7 |
Change price per day: | 0% (1148.7) |
---|---|
Change price per week: | -1.48% (1166) |
Change price per month: | +9.59% (1048.2) |
Change price per 3 month: | -9.55% (1270) |
Change price per half year: | -2.45% (1177.6) |
Change price per year: | +85.69% (618.6) |
Change price per 3 year: | +122.81% (515.55) |
Change price per 5 year: | 0% (1148.7) |
Change price per 10 year: | 0% (1148.7) |
Change price per year to date: | +0.8738% (1138.75) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
iShares MSCI India Small-Cap ETF | 0.35717 | 0.4625 | 0.96163 |
SPDR S&P Emerging Markets Small Cap ETF | 0.13558 | 5.46 | 3.03583 |
iShares MSCI Emerging Markets Small-Cap ETF | 0.13009 | 7.67 | 2.7853 |
![]() |
0.11941 | 5.23 | 1.65591 |
SPDR Portfolio Emerging Markets ETF | 0.07848 | 11.59 | 3.1879 |
![]() |
0.04 | 9.39 | 3.09932 |
Avantis Responsible Emerging Markets Equity ETF | 0.03545 | 17.6 | 3.1719 |
Avantis Emerging Markets Value ETF | 0.03337 | 14.12 | 4.22231 |
Dimensional Emerging Markets Core Equity 2 ETF | 0.02008 | 15.96 | 3.34087 |
Avantis Emerging Markets Equity ETF | 0.01862 | 8.77 | 3.60513 |
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.01728 | 12.46 | 3.59676 |
Dimensional World ex U.S. Core Equity 2 ETF | 0.00801 | 13.06 | 3.62488 |
Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Vaidheesh Annaswamy | Executive Chairman | N/A | |
Mr. Himanshu Agarwal | Chief Financial Officer | N/A | 1970 (55 years) |
Dr. Sudhir Kumar Singh Ph.D. | Chief Executive Officer | 1965 (60 years) | |
Ms. Cyndrella Carvalho | Head of Investor Relations | ||
Mr. Kundan Kumar Jha | Company Secretary & Compliance Officer | ||
Mr. Gaurav Narain Bahadur | Chief Human Resources Officer | 1970 (55 years) | |
Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju | MD & Director | ||
Mr. Subba Raju Komaravolu | Chief Strategy Officer | ||
Mr. Brian Shaughnessy | Chief Commercial Officer | ||
Mr. Sunder Venkatraman | Vice President of Corporate Affairs |
Address: India, Hyderabad, Galaxy Towers - open in Google maps, open in Yandex maps
Website: https://suvenpharm.com
Website: https://suvenpharm.com